KemPharm Inc. | Key People and Executives
Travis C. Mickle
Chairman, President & Chief Executive Officer
David S. Tierney
Independent Director
Joseph B. Saluri
Independent Director
Richard W. Pascoe
Lead Independent Director
Matthew R. Plooster
Independent Director
Danny L. Thompson
Independent Director
Travis C. Mickle
Chairman, President & Chief Executive Officer
Christal M. M. Mickle
Vice President-Operations & Product Development
R. LaDuane Clifton
Chief Financial Officer, Secretary & Treasurer
Sven Guenther
Executive Vice President-Research & Development
Andrew Barrett
Vice President-Scientific Affairs
Rene A. Braeckman
Vice President-Clinical Development
Christopher Lauderback
Vice President-Commercial Operations
Gordon K. Johnson
Chief Business Officer
Timothy J. Sangiovanni
Principal Accounting Officer, Controller & VP
David S. Tierney
Independent Director
Joseph B. Saluri
Independent Director
Richard W. Pascoe
Lead Independent Director
Matthew R. Plooster
Independent Director
Danny L. Thompson
Independent Director
| Address |
1180 Celebration Boulevard
Celebration Florida 34747
United States
|
|
Employees
|
- |
| Website |
http://www.kempharm.com |
| Updated |
07/08/2019 |
| KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses in the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. |
